CLINICAL_TRIALS
trial_result
· 2019-10-30
Clinical Trial Update: An Investigation Into The Anti-hypertensive And Potential Anti-inflammatory Actions Of Dapagliflozin [Phase 4]
Summary
A Phase 4 clinical trial update investigating the anti-hypertensive and potential anti-inflammatory effects of dapagliflozin in type 2 diabetes patients; study …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University at Buffalo | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2019-10-30